DE69209173T2 - Implantationzusammensetzungen, die biologisch aktive Proteine, Peptide oder Polypeptide enthalten - Google Patents

Implantationzusammensetzungen, die biologisch aktive Proteine, Peptide oder Polypeptide enthalten

Info

Publication number
DE69209173T2
DE69209173T2 DE69209173T DE69209173T DE69209173T2 DE 69209173 T2 DE69209173 T2 DE 69209173T2 DE 69209173 T DE69209173 T DE 69209173T DE 69209173 T DE69209173 T DE 69209173T DE 69209173 T2 DE69209173 T2 DE 69209173T2
Authority
DE
Germany
Prior art keywords
biologically active
mixture
composition
peptide
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69209173T
Other languages
German (de)
English (en)
Other versions
DE69209173D1 (de
Inventor
Susan Mancini Cady
David Farley Johnson
Theresa Rice
William David Steber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DE69209173D1 publication Critical patent/DE69209173D1/de
Publication of DE69209173T2 publication Critical patent/DE69209173T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/07—Stiffening bandages
    • A61L15/10—Stiffening bandages containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Prostheses (AREA)
DE69209173T 1991-06-24 1992-04-29 Implantationzusammensetzungen, die biologisch aktive Proteine, Peptide oder Polypeptide enthalten Expired - Fee Related DE69209173T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71989891A 1991-06-24 1991-06-24

Publications (2)

Publication Number Publication Date
DE69209173D1 DE69209173D1 (de) 1996-04-25
DE69209173T2 true DE69209173T2 (de) 1996-11-28

Family

ID=24891827

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69209173T Expired - Fee Related DE69209173T2 (de) 1991-06-24 1992-04-29 Implantationzusammensetzungen, die biologisch aktive Proteine, Peptide oder Polypeptide enthalten

Country Status (24)

Country Link
EP (1) EP0523330B1 (en:Method)
JP (1) JP3597205B2 (en:Method)
KR (1) KR100221031B1 (en:Method)
CN (1) CN1050301C (en:Method)
AT (1) ATE135565T1 (en:Method)
AU (1) AU656200B2 (en:Method)
BR (1) BR9202374A (en:Method)
CA (1) CA2071757C (en:Method)
DE (1) DE69209173T2 (en:Method)
DK (1) DK0523330T3 (en:Method)
ES (1) ES2087337T3 (en:Method)
GE (1) GEP19970992B (en:Method)
GR (1) GR3019457T3 (en:Method)
HU (1) HU217547B (en:Method)
IE (1) IE74398B1 (en:Method)
IL (1) IL102287A (en:Method)
LV (1) LV11816B (en:Method)
MD (1) MD1394G2 (en:Method)
MX (1) MX9203175A (en:Method)
RU (1) RU2080119C1 (en:Method)
SG (1) SG47955A1 (en:Method)
TW (1) TW215058B (en:Method)
UA (1) UA26137C2 (en:Method)
ZA (1) ZA924613B (en:Method)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
BR9912275A (pt) 1998-07-20 2001-04-17 Peptech Ltd Formulação de bioimplante
US8052982B2 (en) 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
JP2001058955A (ja) * 1999-06-17 2001-03-06 Inst Of Physical & Chemical Res 生理活性ペプチド徐放性製剤
KR20080011353A (ko) 2000-02-24 2008-02-01 몬산토 테크놀로지 엘엘씨 소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들
MXPA03000073A (es) 2000-06-26 2003-09-25 Monsanto Technology Llc Formulaciones que contienen agente tensioactivo no acuoso para la liberacion prolongada de somatrotopina.
US6664234B1 (en) 2000-06-30 2003-12-16 Monsanto Technology Llc Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
JP4931282B2 (ja) * 2000-10-02 2012-05-16 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
DE10161078A1 (de) * 2001-12-12 2003-08-28 Achim Goepferich Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen
SE526959C2 (sv) * 2003-10-02 2005-11-29 Tikomed Ab Bioartificellt implantat innefattande en semipermeabel barriär samt förfarande för reducering av risken för bildning av bindrväv vid implantatet efter implantering genom att barriären förses med en permeabel beläggning av bioaktiv metall
JP2005145821A (ja) * 2003-11-11 2005-06-09 Kao Corp 打錠製剤
MX349301B (es) 2009-12-21 2017-07-21 Ambrx Inc Polipéptidos de somatotropina bovina modificados y sus usos.
PE20121799A1 (es) 2009-12-21 2013-01-02 Ambrx Inc Polipeptidos de somatotropina porcina modificados y sus usos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271113A (en) * 1978-04-17 1981-06-02 Alza Corporation Process for forming a passageway in an osmotic device
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
WO1992002211A1 (en) * 1990-08-09 1992-02-20 Endocon, Inc. Multiple drug delivery system

Also Published As

Publication number Publication date
IL102287A0 (en) 1993-01-14
GR3019457T3 (en) 1996-06-30
TW215058B (en:Method) 1993-10-21
RU2080119C1 (ru) 1997-05-27
KR930000131A (ko) 1993-01-15
ZA924613B (en) 1993-03-31
CA2071757C (en) 2003-06-10
CN1068965A (zh) 1993-02-17
GEP19970992B (en) 1997-11-20
CA2071757A1 (en) 1992-12-25
MX9203175A (es) 1993-04-01
LV11816A (lv) 1997-08-20
AU1847092A (en) 1993-01-07
UA26137C2 (uk) 1999-06-07
DK0523330T3 (da) 1996-04-15
KR100221031B1 (ko) 1999-09-15
ES2087337T3 (es) 1996-07-16
CN1050301C (zh) 2000-03-15
SG47955A1 (en) 1998-04-17
MD1394G2 (ro) 2000-11-30
HU9202092D0 (en) 1992-09-28
AU656200B2 (en) 1995-01-27
MD1394F2 (en) 2000-01-31
IE922020A1 (en) 1992-12-30
MD940370A (en) 1996-06-28
HU217547B (hu) 2000-02-28
JPH05186363A (ja) 1993-07-27
BR9202374A (pt) 1993-01-26
ATE135565T1 (de) 1996-04-15
HUT61486A (en) 1993-01-28
EP0523330A1 (en) 1993-01-20
IL102287A (en) 2000-06-01
DE69209173D1 (de) 1996-04-25
LV11816B (en) 1997-12-20
JP3597205B2 (ja) 2004-12-02
EP0523330B1 (en) 1996-03-20
IE74398B1 (en) 1997-07-30

Similar Documents

Publication Publication Date Title
DE69102176T2 (de) Stabile Zusammensetzungen zur parenteralen Anwendung und Verfahren zu ihrer Herstellung.
DE68929273T2 (de) Stabilisierung von Somatotropinen durch Modifikation von Cystein-Resten durch orts-spezifische Mutagenese oder chemische Derivatisierung
DE69209173T2 (de) Implantationzusammensetzungen, die biologisch aktive Proteine, Peptide oder Polypeptide enthalten
DE69802543T3 (de) Verbesserte multipartikel-tablette mit schnellauflösbarkeit
DE69926504T2 (de) Zubereitungen zur kontrollierten freisetzung mit mehrschichtstruktur
DE3782420T2 (de) Wachstumhormonzubereitungen mit verzoegerter wirkstoffabgabe fuer eine parenterale verabreichung und ihre verwendung.
DE3877764T2 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
DE69332081T2 (de) Hydrogelzubereitung mit verzögerter freisetzung
DE3872279T2 (de) Somatropin mit verlaengerter freisetzung.
DE69212497T2 (de) Glasartige kohlenhydratenmatrize zur verabreichung von heilmitteln mit verzögerter wirkstoffabgabe
DE2836631A1 (de) Vaginalpraeparat
DE69201793T2 (de) Mehrschichtige zubereitung mit kontrollierter freisetzung.
DE69128569T2 (de) Tablette mit verzögerter Wirkstoffabgabe
DE69001898T2 (de) Kontrollierte, verzoegerte wirkstofffreisetzung von makromolekularen proteinen.
NZ243221A (en) Implantable medicament composition for the sustained release of proteinaceous substance
DE3413608A1 (de) Implantierbare zubereitungen von regulatorischen peptiden mit gesteuerter freisetzung und verfahren zu ihrer herstellung
EP0859626B1 (de) Cyclosprorin(e) enthaltende pharmazeutische zubereitung zur oralen applikation und verfahren zu ihrer herstellung
DE3830245A1 (de) Calcitonine
DE69633818T2 (de) Verwendung eines mittels zur zur vorbeugung oder behandlung von durch anomalitäten des knorpelgewebes verursachten erkrankungen
DE69734532T2 (de) Futterzusätze für wiederkäuer
DE69103922T2 (de) Verfahren zur Herstellung arzneistoffhaltiger Tabletten mit verzögerter Freigabe.
DE3115080A1 (de) Arzneimittel fuer die orale verabreichung und verfahren zu seiner herstellung
DE69623652T2 (de) Formulierung zur peptidfreisetzung
US5801141A (en) Implant compositions containing a biologically active protein, peptide or polypeptide
DE3884945T2 (de) Emulsion für parenterale verabreichung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WYETH HOLDINGS CORP., MADISON, N.J., US

8339 Ceased/non-payment of the annual fee